Published in Ugeskr Laeger on December 13, 1982
A quantitative assay for HIV DNA integration in vivo. Nat Med (2001) 8.67
Isolation of a fibronectin-binding protein from Staphylococcus aureus. Infect Immun (1982) 2.02
Blood pressure in childhood: pooled findings of six European studies. J Hypertens (1991) 1.68
The primary inhibitor of plasmin in human plasma. Biochem J (1976) 1.64
Accelerating the nonequispaced fast Fourier transform on commodity graphics hardware. IEEE Trans Med Imaging (2008) 1.48
Abuse of monoamine oxidase inhibitors. Am J Drug Alcohol Abuse (1992) 1.38
Mental illness in new neurological patients. J Neurol Neurosurg Psychiatry (2003) 1.36
Adsorption to fibrin of native fragments of known primary structure from human plasminogen. Biochim Biophys Acta (1981) 1.32
Lamellarin alpha 20-sulfate, an inhibitor of HIV-1 integrase active against HIV-1 virus in cell culture. J Med Chem (1999) 1.30
Identification of a highly mobilizable subset of human neutrophil intracellular vesicles that contains tetranectin and latent alkaline phosphatase. J Clin Invest (1990) 1.28
The influence of fixation and tissue preparation on the immunohistochemical demonstration of fibronectin in human tissue. Histochemistry (1981) 1.21
Retroviral cDNA integration: stimulation by HMG I family proteins. J Virol (2000) 1.19
Isolation of Staphylococcus aureus clumping factor. Infect Immun (1985) 1.14
Purification and characterization of a novel, oligomeric, plasminogen kringle 4 binding protein from human plasma: tetranectin. Eur J Biochem (1986) 1.14
Different molecular forms of fibronectin in rheumatoid synovial fluid. Arthritis Rheum (1982) 1.14
Clumping of Staphylococcus aureus by human fibronectin. Acta Pathol Microbiol Scand B (1981) 1.14
Angiogenic balance in human melanoma: expression of VEGF, bFGF, IL-8, PDGF and angiostatin in relation to vascular density of xenografts in vivo. Int J Cancer (2000) 1.09
Properties of three different molecular forms of the alpha 2 plasmin inhibitor. Eur J Biochem (1981) 1.08
Attachment of staphylococci to silicone catheters in vitro. APMIS (1990) 1.08
Fibrin and fibronectin in rheumatoid synovial membrane and rheumatoid synovial fluid. Arthritis Rheum (1983) 1.07
Purification and reaction mechanisms of the primary inhibitor of plasmin from human plasma. Biochem J (1978) 1.06
Kinetic properties of the primary inhibitor of plasmin from human plasma. Biochem J (1977) 1.03
Adverse effects of perioperative paracetamol, NSAIDs, glucocorticoids, gabapentinoids and their combinations: a topical review. Acta Anaesthesiol Scand (2014) 1.02
Comparison of a partially hydrolyzed infant formula with two extensively hydrolyzed formulas for allergy prevention: a prospective, randomized study. Pediatr Allergy Immunol (2000) 1.00
Going virtual with quicktime VR: new methods and standardized tools for interactive dynamic visualization of anatomical structures. Anat Rec (2000) 0.99
Enzymic properties of the neo-plasmin-Val-422 (miniplasmin). Biochim Biophys Acta (1979) 0.96
Primary structure of tetranectin, a plasminogen kringle 4 binding plasma protein: homology with asialoglycoprotein receptors and cartilage proteoglycan core protein. Biochemistry (1987) 0.96
Post-operative analgesic effects of paracetamol, NSAIDs, glucocorticoids, gabapentinoids and their combinations: a topical review. Acta Anaesthesiol Scand (2014) 0.92
Tetranectin immunoreactivity in normal human tissues. An immunohistochemical study of exocrine epithelia and mesenchyme. Histochemistry (1989) 0.92
Neurohormones and oxidative stress in nonischemic cardiomyopathy: relationship to survival and the effect of treatment with amlodipine. Am Heart J (2003) 0.92
Feasibility and patient tolerance of a novel transrectal ultrasound hyperthermia system for treatment of prostate cancer. Int J Hyperthermia (2001) 0.91
Serum ferritin and iron status in mothers and newborn infants. Acta Obstet Gynecol Scand (1987) 0.91
Kinetics of plasmin inhibition in the presence of a synthetic tripeptide substrate. The reaction with pancreatic trypsin inhibitor and two forms of alpha 2-plasmin inhibitor. Biochem J (1981) 0.91
The etiology of hypertension in nonrenovascular unilateral renal disease--two cases of renin induced hypertension in congenital renal dysplasia. Blood Press (1995) 0.90
Familial aggregation of blood-pressure in newly born infants and their mothers. Acta Paediatr Scand (1980) 0.90
Differences in tetranectin immunoreactivity between benign and malignant breast tissue. Histochemistry (1991) 0.90
Tetranectin and plasmin/plasminogen are similarly distributed at the invasive front of cutaneous melanoma lesions. J Pathol (1996) 0.89
Demonstration of fibronectin in human articular cartilage by an indirect immunoperoxidase technique. Histochemistry (1982) 0.89
Biological variation and reference intervals for circulating osteopontin, osteoprotegerin, total soluble receptor activator of nuclear factor kappa B ligand and high-sensitivity C-reactive protein. Scand J Clin Lab Invest (2007) 0.89
Inhibition of urokinase by complex formation with human alpha1-antitrypsin. Biochim Biophys Acta (1976) 0.89
Calcium-dependent binding of tetranectin to fibrin. Thromb Res (1989) 0.88
In vivo demonstration of focal fibrinolytic activity in abdominal aortic aneurysms. Eur J Vasc Surg (1993) 0.88
Demonstration of fibronectin in normal and injured aorta by an indirect immunoperoxidase technique. Histochemistry (1983) 0.88
Fibronectin in experimental granulation tissue. Acta Pathol Microbiol Immunol Scand A (1982) 0.88
Effect of Pseudomonas aeruginosa proteases on human leukocyte phagocytosis and bactericidal activity. Acta Pathol Microbiol Immunol Scand C (1986) 0.87
Properties of fibrinogen-antigenic material on the rheumatoid synovial membrane and in the rheumatoid synovial fluid. J Lab Clin Med (1978) 0.87
Plasma tetranectin is reduced in cancer and related to metastasia. Cancer (1988) 0.87
Beta 2-microglobulin serum levels in infectious mononucleosis in childhood. Acta Pathol Microbiol Scand C (1981) 0.86
Periarticular and generalised bone loss in patients with early rheumatoid arthritis: influence of alendronate and intra-articular glucocorticoid treatment. Post hoc analyses from the CIMESTRA trial. Ann Rheum Dis (2013) 0.86
Tracking of blood pressures in diabetic children. Acta Paediatr Scand (1983) 0.85
Association of body mass index, blood pressure and serum levels of triglycerides and high-density lipoprotein cholesterol in childhood with the insulin sensitivity index in young adulthood: a 13-year follow-up. J Cardiovasc Risk (1996) 0.85
Immunoglobulins and albumin in sputum from patients with cystic fibrosis. A study of protein stability and presence of proteases. Acta Pathol Microbiol Scand C (1980) 0.85
Non-invasive evaluation of bone formation: measurements of serum alkaline phosphatase, whole body retention of diphosphonate and serum osteocalcin in metabolic bone disorders and thyroid disease. Scand J Clin Lab Invest (1988) 0.85
Tetranectin, a trimeric plasminogen-binding C-type lectin. Protein Sci (1997) 0.84
Tetranectin: a novel secretory protein from human monocytes. Scand J Immunol (1993) 0.84
Maternal smoking during childhood and increased risk of smoking in young adulthood. Int J Epidemiol (1995) 0.84
Human serum and plasma increase mouse mortality in Staphylococcus aureus intraperitoneal infection. Acta Pathol Microbiol Immunol Scand B (1984) 0.83
Whole-heart imaging using undersampled radial phase encoding (RPE) and iterative sensitivity encoding (SENSE) reconstruction. Magn Reson Med (2009) 0.83
Inhibition of urokinase by complex formation with human antithrombin III in absence and presence of heparin. Thromb Haemost (1978) 0.83
The primary plasmin inhibitor in rheumatoid synovial fluid. Arthritis Rheum (1977) 0.83
The analgesic effect of wound infiltration with local anaesthetics after breast surgery: a qualitative systematic review. Acta Anaesthesiol Scand (2014) 0.83
Opsonic activity of fibronectin in the phagocytosis of Staphylococcus aureus by polymorphonuclear leukocytes. Eur J Clin Microbiol (1984) 0.82
Immunohistochemical localization of a novel, human plasma protein, tetranectin, in human endocrine tissues. Histochemistry (1987) 0.82
Plasma fibronectin concentrations in patients with liver diseases. Scand J Clin Lab Invest (1983) 0.82
Stromal fibronectin staining pattern and metastasizing ability of human breast carcinoma. Cancer Res (1988) 0.82
Prevalence of antibodies to Epstein-Barr virus (EBV) in childhood and adolescence in Denmark. Scand J Infect Dis (1983) 0.82
Phagocytosis and bactericidal activity of human leucocytes under influence of antimalarial drugs. Trans R Soc Trop Med Hyg (1986) 0.82
The value of hyaluronidase treatment of different tissues before demonstration of fibronectin by the indirect immunoperoxidase technique. Histochemistry (1982) 0.82
Social influences and low leisure-time physical activity in young Danish adults. Eur J Public Health (2001) 0.81
Pre-operative plasma tetranectin as a prognostic marker in ovarian cancer patients. Scand J Clin Lab Invest (1993) 0.81
The influence of plasma proteins on human platelet metabolism. Thromb Res (1979) 0.81
A comparison between nebulized terbutaline, nebulized corticosteroid and systemic corticosteroid for acute wheezing in children up to 18 months of age. Acta Paediatr (1993) 0.81
Partial purification and characterization of a new fast-acting plasmin inhibitor from human platelets. Evidence for non-identity with the known plasma proteinase inhibitors. Biochem J (1980) 0.81
Lipids and lipoproteins in 350 Danish schoolchildren, ages 7 to 18 years. Acta Paediatr Scand (1980) 0.81
Angiostatin generation by human tumor cell lines: involvement of plasminogen activators. Int J Cancer (2000) 0.81
Effects of stringent criteria on eligibility for clozapine among public mental health clients. Psychiatr Serv (1995) 0.81
Enhancement of blood coagulation by soluble fibrin complexes. J Exp Med (1975) 0.81
Sequential appearance of fibronectin and collagen fibres in experimental arthritis in rabbits. Histochemistry (1984) 0.80
Prevalence of fra(X) in the county of Funen in Denmark is lower than expected. Am J Med Genet (1994) 0.80
Viral hepatitis in Danish children. Disappearance of an infection from its previous reservoir. Arch Dis Child (1982) 0.80
Plasma tetranectin and colorectal cancer. Eur J Cancer (1995) 0.80
Coronary heart risk factors in 177 children and young adults whose fathers died from ischemic heart disease before age 45. Acta Paediatr Scand (1982) 0.80
Relative effectiveness of nitroglycerin ointment according to site of application. Heart Lung (1979) 0.80
beta 2-Microglobulin in cerebrospinal fluid from children with different diseases. Acta Paediatr Scand (1980) 0.80
Plasma fibronectin concentration in normal subjects. Scand J Clin Lab Invest (1982) 0.80
Blood lead and erythrocyte zinc protoporphyrin in mothers and newborn infants. Eur J Pediatr (1988) 0.79
Megathrombocytopenia associated with glomerulonephritis, deafness and aortic cystic medianecrosis. Scand J Haematol (1978) 0.79
Tendency towards erosive regression on magnetic resonance imaging at 12 months in rheumatoid arthritis patients treated with rituximab. Ann Rheum Dis (2009) 0.79
Molecular composition and biological properties of soluble fibrin polymers encountered in thrombotic states. Ser Haematol (1973) 0.79
Relationship between blood pressure and urinary albumin excretion rate in young Danish type 1 diabetic patients: comparison to non-diabetic children. Danish Study Group of Diabetes in Childhood. Diabet Med (1994) 0.79
Fibronectin and its role in connective tissue diseases. Eur J Clin Invest (1981) 0.79
Purification of a plasminogen activator inhibitor indistinguishable from alpha1-antitrypsin and an urokinase inhibitor in pregnancy plasma. Haemostasis (1976) 0.78
Prognostic value of serum tetranectin in patients with metastatic breast cancer. Acta Oncol (1993) 0.78
Serum tetranectin and CA-125 used to monitor the course of treatment in ovarian cancer patients. Eur J Obstet Gynecol Reprod Biol (1994) 0.78